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ABSTRACT 
Diclofenac is a Non-Steroidal Anti-Inflammatory Drug (NSAID), which highly inhibits the 
lipoxygenase pathways and reduces the formation of leukotriene lipids. In this work, we report 
on measurements and calculations of the electron density of Diclofenac, obtained from high 
resolution experimental X-ray diffraction data at 110K and theoretical calculations. The 
supramolecular structure is dominated by the formation of a dimer through COOH homo-
synthon. The analysis of the molecular electron density (by means of quantum theory of atoms 
in molecules), the electrostatic potential, the crystal packing and intermolecular interactions 
(through Hirshfeld surface analysis) enables gaining more insight into the nature of the 
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molecule and its ability to interact with other molecules. Furthermore, the topological 
properties of the dimer interactions in both the crystal phase and human transthyretin protein 
environment were identified. The electrostatic potential map shows that the high 
electronegative regions appear around the carboxyl group of the diclofenac molecule in both 
the crystal and protein environment. This study is complemented by a molecular dynamics 
simulation of the interaction of diclofenac with transthyretin protein, which enables to test the 
hypothesis made with the charge density analysis. 
Keywords: 
Experimental Charge density, Hirshfeld surface analysis, topological properties, electrostatic 
interaction, Molecular Dynamics, Quantum Crystallography 
 
1. Introduction 
Diclofenac is the most prominent member of the Non-Steroidal Anti-Inflammatory Drugs 
(NSAIDs) [1], as it inhibits the enzyme cyclo-oxygenase COX-2 [2]. Diclofenac does also 
inhibit the Transthyretin (TTR) [3] protein that carries the thyroid hormone thyroxine (T4) and 
retinol-binding protein bound to retinol. This is how transthyretin gained its name: transports 
thyroxine and retinol. The TTR protein exhibits a β-sheet homo-tetramericthree-dimensional 
structure and has two channels at the dimer–dimer interface.  
This protein may be the main reason for familial amyloid polyneuropathy (FAP), an amyloid 
diseases caused by the TTR fibril formation over the heart and peripheral nerves. Diclofenac 
have been evaluated as a strong in vitro TTR amyloid inhibitor in the reverse mode which 
makes the rotation of dihalogen-substituted ring by 90° with respect to phenylacetic moiety 
[4]. Diclofenac is the best alternative for NSAID drug flufenamic (FLU) [5], which is also a 
biphenylamine derivative with carboxylate substituent, however FLU binds with TTR in 
“forward mode”. The in vitro analysis of this inhibition results with 17-56% reduction of TTR 
fibril formation [6]. 
To the best of our knowledge, the experimental electron density study for this compound has 
not been carried out till date. In order to shed light on the electronic structure of molecules and 
on the molecular recognition processes, high resolution X-ray diffraction measurements on 
crystals and charge density analysis were carried out. These kinds of studies enable the 
determination of the electron density distribution in molecular solids and, from this, a careful 
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analysis of the electrostatic interactions. The charge density derived from experimental models 
can be compared with the theoretically derived, calculated in vacuo or under periodic boundary 
conditions, typically using density functional theory (DFT). The analysis of the static density, 
however, may not be enough for a full comprehension of the molecular aggregation and the 
intermolecular interactions. For this reason, molecular dynamics (MD) simulations may be 
useful to refine the binding conformation of the complex structure and to investigate the 
structural ability of a protein in the presence of ligands. Having this strategy in mind, we have 
undertaken a charge density analysis of diclofenac in order to obtain, from experiment and 
theory, an overview of its structural, topological, reactivity and electrostatic properties. In 
addition, molecular dynamic simulations were carried out to depict a sensible model of the 
actual binding mechanism. This study will provide pathway for exploration of new compounds 
with fewer side effects and a more sophisticated profile than already existing drug molecules, 
which is the focus of chemists and pharmacologists. 
2. Experimental details 
2.1. Crystallization, X-ray data collection and structure solution 
The crystals of diclofenac were grown by slow evaporation method using ethanol solution. 
Among the harvested crystals, a good quality single crystal (ca. 0.12 x 0.14 x 0.19 mm) was 
chosen for high resolution X-ray diffraction experiment. All measurements were made on an 
Oxford Diffraction Super Nova area-detector diffractometer using mirror optics mono-
chromated Mo Kα radiation (λ= 0.71073 Å) and Al filtered [7]. A total of 3600 frames were 
collected in 31 runs with data exposure of 10+10 and 45+45 seconds up to θ<48°, with a 
crystal-detector distance of 65.0 mm, at T = 110(2) K. Data reduction was performed using the 
CrysAlisPro program [7]. The intensities were corrected for Lorentz and polarization effects, 
and an analytical absorption correction was applied, using SCALE3 ABSPACK in CrysAlisPro 
[8]. The smart-background data correction was adopted. 
2.2. Experimental multipole refinement 
The model was refined with MoPro software [9] using Hansen and Coppens [10] multipole 
model for pseudo-atom electron density. The C, N and O atoms were refined up to octapole 
level, hydrogen atoms up to dipole level and chlorine atom was refined up to hexadecapole. 
The core and valence spherical scattering factors were calculated from Su & Coppens [11] and 
the anomalous dispersion coefficients were taken from the International Tables for 
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Crystallography [12]. The parameters of the Slater functions used to describe the multipoles 
are available in the deposited CIF file.  The weighting scheme applied was Whkl = 1/2(I) and 
all reflections were used in all refinements. At first, after structural refinement, the Plm 
multipole populations were refined. In the subsequent steps, the structural and charge density 
parameters were refined successively, in several cycles. In the final stages, all parameters were 
refined simultaneously till convergence. 
According to the values found by the SHADE3 server [13], the Uij thermal displacements 
parameters were fixed for H atoms. The H-X distances of H atoms were restrained to the 
standard values obtained from neutron diffraction studies [14] with a restraint sigma of 0.01Å. 
The crystallographic details of the experimental refinements are given in Table 1. The 
chemically equivalent atoms in the structure were restrained to have similar charge density 
parameters (,’,Pval, Plm) with a restraint sigma r=0.01 [15]. The electron density of atoms 
was restrained to follow the local symmetry (r=0.01). For hydrogen, the  and ’ parameters 
of an atom were restrained to have similar values (k=0.01) and the  values were restrained 
to be equal to 1.16 (k=0.03).   
The most important properties such as the total electron density ρbcp(r), the Laplacian 
, the ellipticity ε at the bond critical points and the eigenvalues (λ1,λ2,λ3) were 
calculated and the experimental deformation maps were estimated and plotted using VMoPro 
module of the MoPro software [9]. The residual indexes and the other parameters of multipole 
refinement are presented in Table 1. The normal probability plot of Iobs-Icalc and the evolution 
of Iobs/Icalc as a function of reciprocal resolution sin/ is shown in Fig. Sup1 and Sup2 [16]. 
The fractal dimension plot of the residual electron density is shown in Fig. Sup3[17]. 
 
3. Theoretical calculations 
A density functional calculation (DFT) was performed in order to understand the electronic 
and reactivity properties for the drug diclofenac using GAUSSIAN09 software [18]. Single-
point calculations were performed once the convergence was reached. The absence of 
imaginary frequencies showed that the minimum energy structure had been achieved. 
Similarly, after the MD simulation, the diclofenac molecule with active site amino acids was 
taken for the single point energy minimization to generate the wave function. The obtained 
wave function for the gas phase of diclofenac molecule and active site region were given as an 
input to the AIM2000 package [19] for calculating the topological properties.  
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3.1. Molecular Dynamics Simulation 
To perform MD simulation, three-dimensional coordinates of the human transthyretin 
complexed with diclofenac (1DVX) complex were retrieved from the Protein Databank. The 
input parameters for the MD simulations were prepared using the default protein force fields 
and the ligand parameters were generated using GAFF force field. The complex was placed at 
the centre of the box and TIP3P water molecules [20] from the AMBER solvent library were 
added into it. Necessary sodium ions were added to neutralize the system. Periodic boundary 
conditions were used to treat the boundary of the system to minimize the edge effects. Particle 
Mesh Ewald (PME) was used to treat electrostatic interactions, the PME grid size was 
73×69×82Ǻ. The resulting system was minimized for 1000 steps and the temperature was 
maintained at 300K throughout the simulation and pressure (1 bar) using the same Langevin 
thermostat and Berendsen barostat used in the heating process [21,22]. 20 ns MD simulation 
was carried out to find out the stability of diclofenac at the active site of human transthyretin 
using the molecular dynamics software NAMD [23] with the time step of one femto-second. 
VMD [24] and CPPTRAJ [25] software were used to generate the MD trajectory. 
4. Results and discussion 
4.1. Crystal structure description 
The crystal volume of diclofenac at 110 K is 3.9% smaller than at ambient conditions, as 
reported by Muangsinet al. [26]. The molecular structure is shown in Figure 1 as an ORTEP 
plot. The 2,6-dichlorophenyl ring and the acid chain lie almost perpendicular to the central 
ring. Despite forming a strong hydrogen bonded dimer, the single and double bond characters 
of the C-O bonds are quite evident: C1-O2 is shorter [1.2314(6)Å] than C1-O1 [1.3080(8)Å] 
(see also Table Sup 1). Compared with the standard C-N bond lengths [27], it is evident that 
some delocalization occurs in the C-N bonds [C8-N1=1.414(5)Å, C9-N1=1.3939(5)Å]. This is 
further confirmed by C8-N1-C9 angle [122.73(3)o] being larger than that of a tetrahedral angle 
which is expected for N1 atom. The electron lone pair of N1 is weakly visible in the electron 
density map and is involved in the resonance. Another reason for the large angle might be the 
C9 atom is attached with the 2,6-dichlorophenyl ring. In order to get details regarding the 
distortion in bond angles, the deformation of C-C-C valence angles has been calculated for the 
2,6-dichlorophenyl ring and the other phenyl ring separately. The root means square deviations 
from the ideal 120° value of the hexagonal angles is computed as: 
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It is found that the distortion in angle for the 2,6-dichlorophenyl ring is higher (σhexagon=2.2°) 
than that of the other phenyl ring of the molecule (σhexagon=0.65°) and the reason might be 
presence of the two Cl atoms and their electron withdrawing effect on the C6 ring. 
4.2. Crystal packing and intermolecular interactions 
The main feature of the supramolecular packing is the coupling of two carboxylic groups 
forming a strongly hydrogen bonded dimer (Fig.2a), through O1-H1B∙∙∙O2 interactions. The 
packing of the molecule along b axis is given in Fig.2b.There are anyway other contacts, such 
as C-H∙∙∙Cl and C-H∙∙∙O, that also give contributions to the packing of the crystal. The Hirshfeld 
surface analysis [28,29] summarises all the contributions and it certainly highlights major role 
played by O1-H1B∙∙∙O2 interaction (Fig.3). The hydrogen bonding details are given in Table 2 
There is limited non-parallel cycle stacking present between 2,6-dichlorophenyl rings. A dimer 
formed via an inversion centre results in a Cl∙∙∙Cl distance of 3.576 Å which is shorter than the 
sum of Van der Waals radii (Fig. 3b). The experimental Cl∙∙∙Cl interaction which is traced in 
our molecule is comparable with the type I trans Cl∙∙∙Cl geometry as reported by Hathwar and 
Guru Row [30].  
The fingerprint analysis (Fig.4) [31] shows that H∙∙∙H contacts (Fig. 4b) give the largest 
contribution, which is about 32.5%. The Cl∙∙∙H/H∙∙∙Cl (Fig.4c) and O∙∙∙H/H∙∙∙O hydrogen bonds 
(Fig.4d) also render a significant contribution of 18.7% and 13.6% respectively to the packing.  
4.3. Contact Enrichment Ratio Analysis 
The contacts enrichments [32]have been analysed with software MoPro Viewer[33]. The 
enrichment ratio, which compares the actual contacts with equi-probable theoretical contacts 
(derived from the chemical content on the surface), enables to see if interactions are over or 
under-represented. Hydrophobic hydrogen atoms Hc bound to C were distinguished from polar 
Hp atoms bound to O or N atoms. The four major contacts are hydrophobic, of type C∙∙∙Hc, 
C∙∙∙Cl, Cl∙∙∙Hc and Hc∙∙∙Hc (Table 3, Fig. 5). Among these four contacts, three are close to a 
balanced representation (E1) while Cl∙∙∙C contacts are significantly over-represented with 
EC.Cl=1.54 due to numerous C-Cl∙∙∙C interactions. Weak hydrogen bonds of type Cl∙∙∙Hc are 
also well represented.  
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According to the recent study by Eskandariet al. [34], halogen bonding can be described as an 
interaction between a depleted region also known as a -hole on the halogen atom and a charge 
concentrated region also known as a lump on the other molecule. One Cl∙∙∙Cl halogen bond 
occurs in the crystal (Fig. 3b) but this type of contact is under-represented, similarly to the 
Cl∙∙∙O halogen bonds. The C∙∙∙C contacts are impoverished at E=0.68 due to the occurrence of 
very limited non-parallel cycle stacking. C∙∙∙Hc contacts are more represented as significant C-
H∙∙∙π interactions are seen, notably between phenyl rings forming an angle of 85.1° and related 
by two-fold helical axis of direction b (Fig. 2b).  
 The most enriched contact at E= 5.0 is between polar Hp (H-O and H-N) hydrogen atoms and 
oxygen, although it represents less than 5% of the contact surface. The O∙∙∙H-O strong double 
hydrogen bond constitutes the most attractive electrostatic interaction in the crystal packing. 
Besides that, the oxygen atoms are mostly involved in weak C-H∙∙∙O hydrogen bonds which 
are slightly favoured at EO.Hc= 1.06. The nitrogen atom, despite its hydrogen bond acceptor 
potential, is mostly surrounded by carbon atoms. On the other hand, the H-N nitrogen atoms 
which forms an intramolecular hydrogen bonds with the C1=O2 carbonyl is only surrounded 
by Hc atoms. Globally, the molecular surface contains 86 % of hydrophobic atoms (C, Hc, Cl) 
and 14% of hydrogen bond donors/acceptors (Hp, O). When this partition of the molecule is 
considered, it can be derived from Table 3, that the contacts between hydrophilic contacts 
appear quite enriched at E=2.6. The hydrophobic ones are slightly overrepresented at E=1.04 
while cross contacts between polar/non-polar atoms are significantly disfavoured at E=0.76.  
4.4. Molecular electron density 
The quality of the high resolution data and the multipole model is attested by the residual 
density map for the phenyl ring in the molecule and is shown in Fig.6.  
The topological properties of the electron density are listed in Table 4 and in Table S2 of the 
Supporting information. The most relevant results concern the heteronuclear Cl-C and the C-
N bonds. The C-Cl bonds show lower magnitudes of ρ(r) and 2ρ(r) at the bond critical point. 
This reflects the weak shared interactions occurring between these atoms. Moreover, the 
bonding density peaks are closer to the carbon atom and their positions do not correspond to 
that of the CPs, resulting in weaker ρ(rcp) and 2ρ(rcp) values. The electron density was found 
to be polarized towards the chlorine atom, bearing the negative charge. The corresponding 
experimental/theoretical electron density and Laplacian of electron density for the C14-Cl1 and 
C10-Cl2 bond critical points are 1.29/1.35eÅ-3 ; 1.31/1.38 eÅ-3 and -1.8/-7.2 eÅ-5 ;-2.2/-7.6 eÅ-
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5 respectively, and this was well agreed with the earlier reported values [35]. We note that 
theoretical calculations predict the critical point closer to the region of negative Laplacian of 
the Chlorine atoms, at variance from the multipolar model adopted for the experimental 
electron density.    
As anticipated in section 4.1, the C-N bonds display values which are larger than for typical 
single bonds and effects of the electron delocalization are visible. Anyway, the two bonds are 
not identical: C8-N1 [1.414(6)Å] is comparatively longer than C9-N1 [1.394(5)Å] which 
shows a weaker π-donating effect of the amine nitrogen atom towards the phenyl ring compared 
to the 2,6-dichlorophenylring. 
As for the two C-O bonds, C1-O2 is stronger and it clearly shows the localized nature of the 
double bond, compared with C1-O1, a localized single bond. In fact, at the bond critical points, 
the electron density is 2.83e/Å3(Expt.) or 2.70 e/Å3 (Theor.) for C1-O2 and 2.33 e/Å3 (Expt.) 
or 2.17 e/Å3(Theor.) for C1-O1. 
 The deformation maps in the 2,6-dichlorophenyl (Fig. 7a) and phenyl ring (Fig. 7b) provide a 
pictorial view of the electron density depicting the bonding regions and electron lone pairs of 
the molecule. This information is in keeping with that provided by the Laplacian maps(Fig. 8a-
8c).  
4.5. Molecular electrostatics 
The molecule features some regions of strongly negative electrostatic potentials and others 
dominated by a positive potential. Of course, this mirrors the distribution of charges in the 
molecule. The carboxylic group consists of carbon C1, which bears the highest positive 
QTAIM charge (+1.536e, see Table 5) and of the two electronegative O atoms O1 (-1.071e) 
and O2 (-1.245e). Comparatively, the O2 atom (O2=C) has slightly more negative charge than 
the O1 atom (C1-O1-H1B). The aminic N1 atom bears the second most negative charge and 
the electron rich region around the atom is clearly seen in the Fig. 9b. The group charges on 
the 2,6-dichlorophenyl ring, the other phenyl ring and the acid chain are calculated as +0.285e, 
+0.367e and +0.030e, respectively. The phenyl ring has an electropositive contribution on the 
molecule while the 2,6-dichlorophenyl ring is more electronegative. The Cl2 atom has slightly 
larger volume (109.6Å3) than the Cl1 atom (102.1Å3) (as listed in Table 5).  
The electrostatic potential maps of the intermolecular interactions are shown in Fig. 9c in 
which, the high negative potential is observed around the vicinity of carboxyl group of the 
9 
 
diclofenac molecule in both the crystal and TTR protein environment. From this, it was 
confirmed that the carboxyl group of diclofenac molecule plays an important role in the drug-
receptor interactions.  
4.6. Topological properties for Intermolecular interactions in crystal and active site 
phase 
Topological properties of the strong intermolecular interactions in the crystal and protein 
environment were determined by using charge density analysis to understand the strength of 
intermolecular interactions at electronic level, which plays vital role in the molecular 
recognition of bio-systems [36,37]. Numerous reports clearly explained about the topological 
properties of intermolecular interactions [38–42]. However, the same properties were 
calculated and compared for diclofenac molecule in the solid state and human transthyretin 
enzyme environment with the help of (3,-1) type of critical point search. In the crystal phase, 
the electron density and Laplacian of electron density of H(1B)∙∙∙O(2) interaction is 0.30 eÅ-3 
and 5.19 eÅ-5 respectively. The Laplacian map of the interaction is shown in Fig. 10a,b; a lone 
pair of the oxygen atom is directed towards the hydrogen atom. The carboxyl group of the 
diclofenac molecule forms strong dimer interactions in the solid state and the same group forms 
strong interaction in the protein environment. In the human transthyretin-diclofenac complex, 
the electron density and Laplacian of electron density of O(2)∙∙∙H−O Ser117 interaction is 0.149 
eÅ-3 and 2.113 eÅ-5 respectively and the interaction is shown in Fig. 10c. On comparing both 
the electron density and Laplacian of electron density of the particular interaction in the solid 
state and protein phase, the ρ(rbcp) and 2ρ(rbcp) values are decreased when the molecule enters 
into the active site of human transthyretin enzyme. This is strongly attributed to the effect of 
the protein environment. Furthermore, the total energy densities of the intermolecular 
interactions were calculated from the sum of kinetic energy and potential energy as stated by 
viral theorem [43–45]. The topological properties [ρ(rbcp) and2ρ(rbcp)], the total energy 
density (Hr), potential energy density (Vr), kinetic energy density (Gr), bond dissociation energy 
(D), bond path length (Rij) and bond critical point distances (d1 and d2) of intermolecular 
interactions are presented in Table 6. The negative kinetic energy dominates the potential 
energy and, as a result, the total energies are negative. 
4.7. Reactivity properties 
   The analysis on HOMO-LUMO plays a vital role in explaining the process of charge transfer 
within the molecule. The HOMO-LUMO energy gap characterizes the kinetic stability and 
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chemical reactivity of the molecule. Some global reactivity descriptors such as electron affinity 
[46], ionization potential, hardness [47,48], softness, electronegativity [49] and electrophilicity 
index [50,51] help us to characterize the nature and interaction of the molecule. The reactivity 
descriptors have been listed in Table 7. The low energy gap between the donor and acceptor 
shows that the transfer of energy takes place well between them. The very low electron affinity 
(0.031a.u.) and low ionization potential (0.213a.u.) says that the molecule has low kinetic 
stability as well as high chemical reactivity. The very low global hardness value (0.091a.u.) 
and very high softness value (5.495a.u.) pronounces that the molecule is ready to share 
electrons and it is termed as very soft molecule. The very low electronegativity (0.122a.u.) 
predicts that the molecule has very low attraction for electrons. Moreover, the low 
electrophilicity index (0.086a.u.) tells that the molecule can act as nucleophile which could 
donate electrons while interacting with the bio-molecule.  
4.8. Intermolecular interactions and stability of the complex 
MD simulation is a trustful tool to validate the conformational changes, stability of human 
transthyretin-diclofenac complex and intermolecular interactions. The stable conformation of 
diclofenac was positioned initially in the active site, as in the PDB coordinates file.  
There are few statistical parameters to evaluate the conformational stability and strength of 
intermolecular interactions such as root mean square deviation (RMSD), root mean square 
fluctuation (RMSF), radius of gyration (Rg) and number of hydrogen bonding in the protein-
ligand complex. The RMSD of the transthyretin-diclofenac complex was calculated with 
respect to initial coordinates to understand the deviation of the backbone of the protein. The 
maximum RMSD of the complex is 1.5 Å, which indicates that the complex is stable during 
the 20 ns of MD simulation (Fig.11 and Fig. 12). The RMSF of the transthyretin-diclofenac 
complex clearly indicates that larger fluctuation was noticed in the loop regions of the complex 
than in the α-helix and β-sheet domain. The maximum fluctuation of the complex during the 
simulation is ~3 Å in the loop region which is not stabilized by intermolecular interactions. 
Particularly, the active site amino acids are not fluctuating highly; the RMSF of these amino 
acids is ~2 Å. The radius of gyration of the transthyretin-diclofenac complex is determined to 
understand the compactness of the protein when the ligand molecule enters into the active site 
of the protein. The average Rggyration radius value of the transthyretin-diclofenac complex is 
~17.7663 Å (with standard deviation of 0.10848); which indicates that the complex is highly 
stable during the MD simulation. The number of hydrogen bonding interactions in the 
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transthyretin-diclofenac complex comprise ~120 (within the protein) and 3 (between the 
protein and ligand) (Fig. 11d). Notably, the carboxyl group of the diclofenac molecule is 
forming strong interactions with active site residues which is clearly shown in the Fig. 12. 
Apart from the direct hydrogen bonds, water mediated hydrogen bonds and hydrophobic 
clusters stabilize also the orientation. The H-C hydrogen atoms involved in the cluster 
formation belong to amino acids SER 108, THR 109, THR 110 and SER 221. The electrophilic 
and nucleophilic regions of the ligands interact with the nucleophilic and electrophilic regions 
of the protein active site, respectively. The Connolly surface view of the transthyretin-
diclofenac complex clearly shows the binding cavity. The superimposed view of the 
transthyretin-diclofenac complex also confirms its stability (Fig.12). On comparing the crystal 
and simulated transthyretin-diclofenac complex, the relative orientation of the dichlorobenzene 
and phenyl ring of the diclofenac molecule is different; this can clearly be attributed to the 
effect of interactions and to the dynamical behaviour. 
5. Conclusion 
The experimental electron density analysis of the diclofenac molecule was performed at 110K 
using high-resolution X-ray diffraction data. The aminic N1 atom, which has three bonds, could 
be expected to have tetrahedral geometry (sp3). The structure analysis shows that it is, instead, 
closer to a trigonal geometry (sp2) but it still has a weak electron lone pair. This can be 
attributed to the involvement of N1 atom in resonance primarily with the aromatic 2,6-
dichlorophenyl ring. The C8-N1 bond is comparatively longer than the bond C9-N1 which 
shows a weaker π-donating effect of the amine nitrogen atom towards the phenyl ring than 
towards the 2,6-dichlorophenyl ring.  
The interaction between  two parallel aromatic rings results in a Cl…Cl distance shorter than 
the sum of van der Waals radii. The O2=C1 oxygen atom is considered to be the most 
nucleophilic and it is the preferred site of electrophilic attack. The drug proves as a potent drug 
and physiologically active according to the Lipinski rule of five parameters. The reactivity 
descriptors describes that diclofenac has high chemical reactivity, is very soft and is a fast 
interacting drug with the biomolecules. The molecular dynamics simulation, started from 
crystal structure of the complex, shows a clear picture of the interaction between the diclofenac 
molecule and the amino acid residues present in the human transthyretin protein. 
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Table 1 Crystallographic and refinement details. 
Crystal data 
Chemical formula C14H11Cl2NO2 
Mr 296.14 
Crystal system, space group Monoclinic, C2/c 
Temperature (K) 110 
a, b, c (Å) 20.0817 (2), 6.8873(4), 19.8429 (2) 
β (°) 109.749 (1) 
V (Å3) 2583.02(4) 
Z 8 
Radiation type Mo Kα 
µ (mm−1) 0.50 
Crystal size (mm) 0.12 × 0.14 × 0.19 
Data collection 
Diffractometer Oxford Diffraction SuperNova 
Absorption correction Multiscan(Abspack, CrysAlisPro 1.171.38.43) 
Tmin, Tmax 0.705, 1.00 
No. measured;unique; 
observed [I> 2σ(I)] reflections 
109947; 12271;9581  
(sin θ/λ)max (Å−1) 1.043 
Refinement 
R[F2> 2σ(F2)], wR(F2), S 0.034, 0.054, 0.982 
No. of reflections 11436 
No. of parameters 609 
H-atom treatment H atoms treated by a mixture of independent and 
constrained refinement 
Δρmax, Δρmin (e Å−3) 0.41, −0.41 
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Table 2 Hydrogen bonding details. 
Bonds D-H(Å) H∙∙∙A(Å) D∙∙∙A(Å) D-H∙∙∙A(o) 
O1-H1B∙∙∙O2#1 0.979 1.649 2.628(1) 178.1 
C2-H2A∙∙∙O2#2 1.071 2.562 3.633(1) 166.3 
C6-H6∙∙∙Cl1#3 1.031 2.771 3.802(1) 150.0 
Symmetry codes: #1. -X+ ½ ; -Y+5/2 ; -Z+1   #2.-X+½ ; -Y+3/2 ; -Z+1,  #3. -X+1 ; Y ; -Z+3/2 
 
Table 3 Nature of intermolecular contacts on the Hirshfeld surface by chemical types. 
chem. C Hc Cl Hp O 
surf. % 29.5 35.1 20.8 5.6 8.3 
C 5.7 
 
Hc 21.8 12.6 % contacts 
Cl 18.8 14.7 2.3 
Hp 1.3 2.6 2.5 0.2 
O 3.6 6.2 1.9 4.8 0.0 
C 0.68         
Hc 1.07 1.02 enrichment   
Cl 1.54 0.98 0.50     
Hp 0.37 0.63 1.03 0.61   
O 0.75 1.06 0.53 5.0 0.00 
 
The second row contains the contribution SX of each chemical type X on the Hirshfeld. The third part 
of the Table show the %Cxy of the contact types on the surface. The lower part of the Table shows the 
Exy enrichment ratios of contact types. The major Cxy contact types and the Exy ratios larger than unity 
(corresponding to the significantly enriched contacts) are highlighted in bold characters. The 
hydrophobic Hc atoms bound to carbon were distinguished from the more polar Hp hydrogen atom 
from the COOH and NH groups. Chemical types have been regrouped in hydrophobic (C, Hc, Cl) and 
charged (Ho, O) atoms. N chemical type is omitted as it represents only 0.5% on the contact surface. 
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Table 4 Topological properties of the electron density at the bond critical points of 
Diclofenac. 
Bonds ρbcp 
(e/Å3) 
2ρbcp 
(e/Å5) 
ε d1 
(Å) 
d2 
(Å) 
 (C-C)aro 2.1(2) -18.4(6) 0.198(2) 0.697 0.617
 C2-C3 1.65(2) -9.4(5) 0.0(2) 0.728 0.785
 C14-Cl1 1.29(1) -1.8(4) 0.11(5) 0.96 0.777
 C10-Cl2 1.31(2) -2.2(5) 0.02(5) 0.956 0.769
C1-O1 2.33(4) -27.7(2) 0.09(3) 0.813 0.495
 C1-O2 2.83(8) -22.2(7) 0.18(4) 0.814 0.417
C8-N1 2.00(2) -16.6(1) 0.12(2) 0.822 0.593
 C9-N1 2.13(3) -15.7(1) 0.14(4) 0.78 0.614
 (C-H)aro 1.82(2) -16.8(7) 0.04(2) 0.723 0.359
 (C-H)sp3 1.74(0) -13.9(0) 0.01(1) 0.716 0.375
 O1-H1B 2.10(4) -23.7(3) 0.003(4) 0.754 0.226
 N1-H1A 2.03(4) -21.2(1) 0.05(2) 0.756 0.259
 
 
 
Table 5 Experimental integrated topological atomic charges and volumes. 
Atom Q(e) Atom Q(e)  
Cl1 -0.157 C11 -0.022  
Cl2 -0.177 C12 -0.124  
O1 -1.071 C13 -0.024  
O2 -1.245 C14 -0.009  
N1 -1.111 H2A 0.132  
C1 1.536 H2B 0.132  
C2 -0.048 H4 0.147  
C3 -0.146 H5 0.129  
C4 -0.218 H6 0.129  
C5 -0.009 H7 0.189  
C6 -0.121 H11 0.148  
C7 0.013 H12 0.14  
C8 0.253 H13 0.16  
C9 0.28 H1A 0.444  
C10 0.053 H1B 0.597  
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Table 6. Topological properties of electron density for the main intermolecular interactions in 
the crystal phase and active site region. G and V are the kinetic, potential energy respectively. 
Bond cp(rcp) 
e/Å3 
2(rcp) 
e/Å5 
Ellip. G(rcp) 
  au 
V(rcp) 
  au 
d1 
(Å) 
d2 
(Å) 
O1-H(1B)∙∙∙O2#1 0.301(3) 5.19(5) 0.03(2) 0.052 -0.050 1.649 1.114 
C2-H(2A)∙∙∙O2#2 0.033(2) 0.64(2) 0.11(1) 0.005 -0.003 1.554 1.023 
C6-H6∙∙∙Cl1#3 0.038(2) 0.66(1) 4.33(5) 0.005 -0.003 1.812 1.034 
O2∙∙∙H−O Ser117 0.149 2.113 0.07 0.03 -0.04 0.756 1.248 
                                    #1. -X+1/2 ; -Y+5/2 ; -Z+1   #2.-X+1/2 ; -Y+3/2 ; -Z+1,  #3. -X+1 ; Y ; -Z+3/2 
 
Table  7.  Reactivity descriptors of the Diclofenac molecule. 
 
 
 
 
 
Molecular descriptor Energy(a.u.) 
Electron affinity   
A=[-ELUMO] 0.031
Ionization potential   
I=[-EHOMO] 0.213
Global hardness   
Η=(I-A)/2 0.091
Softness   
S= ½ η 5.495
Electronegativity   
Χ=(I+A)/2 0.122
Electrophilicity index   
Ω=μ2/2η 0.086
HOMO energy -0.213
LUMO energy -0.031
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Fig. 1. ORTEP view of the diclofenac molecule, showing the atom-numbering scheme. 
Displacement ellipsoids are drawn at the 50% probability level. 
 
 
Fig. 2. a) Crystal packing of diclofenac molecule along the b axis. 
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(b) Crystallographic auto stereogram [52] showing translations along the short axis b= 6.89Å 
 
Fig. 3.a) Hirshfeld surface showing the strength of the COOH  homo-synthon interaction in a 
dimer. 
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b) View of halogen…halogen type I trans Cl…Cl geometry between two parallel aromatic 
rings. 
 
 
Fig. 4. Fingerprint plots: (a) full, (b) resolved into H…H and (c) Cl∙∙∙H/ H∙∙∙Cl  d) O∙∙∙H/H∙∙∙O 
contacts, showing the percentages of contact contributing to the total Hirshfeld surface area 
of the diclofenac molecule in the crystal. 
 
 
 
 
 
 
 
(a)                                 (b) 
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(c)                                                     (d)  
Fig. 5. Hirshfeld surface coloured according to the interior (a) exterior (b) atom contributing 
most to the electron density. The view was made with MoPro Viewer. The orientation of the 
molecule is also shown. Carbon: dark grey, hydrogen Hc: grey, chlorine: green, oxygen: red, 
polar hydrogen Hp: yellow 
(a) 
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      (b) 
 
 
Fig. 6. Residual electron density map of the phenyl ring. CutoffI>2σ(I), contour 0.05 e/Å3. 
Blue lines represent positive contours and red lines represent negative contours and the green 
lines are zero contours. 
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Fig. 7. Deformation electron density map for a) 2, 6-dichlorophenyl and b) Phenyl ring. 
Contour intervals are 0.05 eÅ-3; blue lines are positive contours, red lines are negative 
contours and green lines are zero contours. 
                             
(a)       (b) 
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Fig. 8. Laplacian of the electron density for the (a) 2,6-dichlorophenyl, (b) Phenyl ring. Solid 
blue and dotted red lines represent the positive and negative contour lines respectively. Contour 
levels are 2, 4, 8, 10n, n = –1, 0, 1 The bond critical points positions are shown by black crosses. 
(c) 3D view of the Laplacian of total electron density around the N1 atom. Contour level: -40 
e/Å3.  
                                    (a)       (b) 
  
 ( c)  
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C)  
 
Fig. 9. Electrostatic potential maps. Contour levels, red negative V=-0.3eV, blue: positive 
V=0.5eV (a) around the diclofenac molecule, (b) around the O1-H1B∙∙∙O2 interaction.  
(c) around the interaction between O1-H1B∙∙∙O2 of diclofenac molecule and Ser117 of the 
transthyretin protein. 
                 (a)  
 
(b)  
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(c)  
Fig. 10. (a) Laplacian of the electron density of O1-H1B…O2 interaction (b) Relief map (c) 
Laplacian map of the interaction between O-H of Ser117 and O2. Contour level 2, 4, 8, 10n, n 
= –1, 0, 1. 
 
(a)                                                        (b) 
 
 
 
 
 
 
                                                                       (c)  
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Fig. 11.View of the (a) RMSD, (b) RMSF, (c) radius of gyration and (d) number of hydrogen 
bonding present in the human transthyretin enzyme. 
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Fig.12. The diclofenac molecule at the binding site of human transthyretin enzyme in 
different views. 
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Supporting information  
Table Sup 1: Selected geometric parameters (Å, º) 
Cl1—C14 1.7366 (4) C4—C5 1.3921 (6) 
Cl2—C10 1.7249 (4) C5—C6 1.3905 (6) 
O1—C1 1.3080 (8) C6—C7 1.3919 (6) 
O2—C1 1.2314 (6) C7—C8 1.3977 (5) 
N1—C9 1.3939 (5) C9—C14 1.4045 (6) 
N1—C8 1.4141 (5) C9—C10 1.4069 (5) 
C1—C2 1.5072 (6) C10—C11 1.3894 (6) 
C2—C3 1.5135 (6) C11—C12 1.3902 (7) 
C3—C4 1.3933 (6) C12—C13 1.3900 (6) 
C3—C8 1.4066 (5) C13—C14 1.3902 (6) 
C9—N1—C8 122.73 (3) C3—C8—N1 118.19 (3) 
O2—C1—O1 123.67 (5) N1—C9—C14 121.47 (3) 
O2—C1—C2 121.62 (4) N1—C9—C10 122.36 (3) 
O1—C1—C2 114.70 (4) C14—C9—C10 115.99 (3) 
C1—C2—C3 110.08 (3) C11—C10—C9 122.02 (3) 
C4—C3—C8 119.58 (3) C11—C10—Cl2 120.02 (4) 
C4—C3—C2 119.82 (3) C9—C10—Cl2 119.55 (3) 
C8—C3—C2 120.60 (3) C12—C11—C10 120.02 (4) 
C5—C4—C3 120.97 (3) C13—C12—C11 119.78 (4) 
C6—C5—C4 119.27 (4) C12—C13—C14 119.33 (3) 
C5—C6—C7 120.54 (4) C13—C14—C9 122.75 (3) 
C6—C7—C8 120.33 (3) C13—C14—Cl1 118.59 (3) 
C7—C8—C3 119.30 (3) C9—C14—Cl1 118.66 (3) 
C7—C8—N1 122.50 (3) 
O2—C1—C2—C3 68.74 (6) C8—N1—C9—C14 −123.99 (6) 
O1—C1—C2—C3 −109.81 (7) C8—N1—C9—C10 61.14 (6) 
C1—C2—C3—C4 98.14 (7) N1—C9—C10—C11 178.67 (6) 
C1—C2—C3—C8 −81.68 (7) C14—C9—C10—C11 3.64 (7) 
C8—C3—C4—C5 −0.98 (6) N1—C9—C10—Cl2 1.28 (5) 
C2—C3—C4—C5 179.20 (6) C14—C9—C10—Cl2 −173.85 (4) 
C3—C4—C5—C6 0.07 (6) C9—C10—C11—C12 −1.98 (6) 
C4—C5—C6—C7 0.35 (6) Cl2—C10—C11—C12 175.44 (5) 
C5—C6—C7—C8 0.17 (7) C10—C11—C12—C13 −0.85 (6) 
C6—C7—C8—C3 −1.09 (6) C11—C12—C13—C14 2.89 (7) 
C6—C7—C8—N1 177.74 (6) C12—C13—C14—C9 −0.26 (8) 
C4—C3—C8—C7 1.48 (6) C12—C13—C14—Cl1 −179.84 (5) 
C2—C3—C8—C7 −178.70 (6) N1—C9—C14—C13 −177.66 (6) 
C4—C3—C8—N1 −177.40 (6) C10—C9—C14—C13 −2.47 (6) 
C2—C3—C8—N1 2.42 (6) N1—C9—C14—Cl1 2.02 (5) 
C9—N1—C8—C7 15.85(6) C10—C9—C14—Cl1 177.20(4) 
C9—N1—C8—C3 −165.32 (6) 
 
Table Sup 2: Experimental and  theoretical topological properties of the electron density at the 
bond critical points of Diclofenac. 
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Bonds 
ρBCP 
(e/Å3) 
 𝜵𝟐𝝆 
( e/Å5) 
ε 
d1 
(Å) 
d2 
(Å) 
C2-C3 1.65(2) -9.4(8) 0.00(2) 0.728 0.785 
 1.66 -13.4 0.04 0.758 0.755 
 C3-C4 2.18(2) -18.9(7) 0.26(2) 0.686 0.707 
 2.09 -20.7 0.22 0.685 0.707 
 C3-C8 2.11(2) -17.7(7) 0.29(2) 0.693 0.714 
 2.06 -20.2 0.24 0.717 0.69 
 C4-C5 2.17(2) -18.8(5) 0.19(4) 0.708 0.685 
 2.09 -20.9 0.19 0.689 0.702 
 C5-C6 2.17(2) -19.3(7) 0.17(2) 0.685 0.360 
 2.11 -21.2 0.19 0.697 0.691 
 C6-C7 1.81(2) -15.8(8) 0.02(2) 0.708 0.374 
 2.08 -20.7 0.20 0.700 0.692 
 C7-C8 1.85(3) -17.6(9) 0.05(2) 0.718 0.365 
 2.08 -20.6 0.22 0.673 0.724 
 C9-C10   2.10(1) -17.5(4) 0.27(2) 0.698 0.709 
 2.05 -19.8 0.27 0.700 0.707 
 C9-C14   2.14(2) -17.9(5) 0.27(3) 0.697 0.709 
 2.06 -19.9 0.27 0.707 0.698 
 C10-C11  2.18(3) -19.7(8) 0.23(2) 0.709 0.681 
 2.09 -20.8 0.23 0.663 0.727 
 C11-C12  2.16(2) -19.397) 0.21(1) 0.680 0.710 
 2.10 -21.1 0.19 0.688 0.700 
 C12-C13  2.15(2) -19.1(7) 0.19(1) 0.711 0.679 
 2.10 -21.1 0.20 0.700 0.688 
 C13-C14  2.18(2) -19.4(7) 0.23(2) 0.674 0.716 
 2.10 -20.8 0.23 0.663 0.728 
 C14-Cl1  1.29(1) -1.8(4) 0.11(5) 0.960 0.777 
 1.35 -7.2 0.07 0.995 0.743 
 C10-Cl2  1.31(2) -2.2(5) 0.02(5) 0.956 0.769 
 1.38 -7.6 0.07 0.737 0.989 
 C1-O1 2.33(4) -27.7(2) 0.09(3) 0.813 0.495 
 2.17 -7.6 0.04 0.444 0.867 
 C1-O2 2.83(8) -22.2(7) 0.18(4) 0.814 0.417 
 2.70 -9.0 0.08 0.807 0.423 
 C8-N1 2.00(2) -16.6(1) 0.12(2) 0.822 0.593 
 1.92 -19.3 0.08 0.551 0.865 
 C9-N1 2.13(3) -15.7(1) 0.14(4) 0.780 0.614 
 2.02 -21.1 0.11 0.548 0.848 
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 C4-H4 1.85(3) -18.1(7) 0.05(1) 0.723 0.360 
 2.63 -42.6 0.001 0.545 0.367 
 C5-H5 1.81(2) -15.8(7) 0.02(1) 0.708 0.374 
 2.63 -42.5 0.004 0.546 0.367 
 C6-H6 1.85(2) -17.6(8) 0.05(2) 0.718 0.365 
 2.64 -42.9 0.003 0.366 0.547 
 C7-H7 1.78(2) -16.5(7) 0.04(2) 0.740 0.343 
 2.63 -42.7 0.008 0.364 0.549 
 C11-H11  1.82(1) -16.1(6) 0.03(2) 0.727 0.356 
 2.64 -43.2 0.008 0.552 0.36 
 C13-H13  1.81(2) -16.1(6) 0.01(1) 0.729 0.354 
 2.64 -43.2 0.008 0.359 0.553 
 C12-H12  1.83(2) -17.7(7) 0.06(2) 0.719 0.364 
 2.63 -42.8 0.003 0.363 0.549 
 C2-H2A   1.72(2) -13.7(5) 0.01(1) 0.716 0.376 
 2.42 -36.4 0.01 0.358 0.596 
 C2-H2B   1.76(3) -14.1(6) 0.01(1) 0.716 0.375 
 2.42 -36.5 0.012 0.591 0.363 
 O1-H1B   2.10(4) -23.7(3) 0.003(4) 0.754 0.226 
 2.68 -70.7 0.02 0.151 0.755 
 N1-H1A   2.03(4) -21.2(1) 0.05(2) 0.756 0.259 
 3.95 -114.2 0.04 0.148 0.626 
36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The first line indicates the experimental values; the second line indicates the values obtained from the 
gas phase theoretical calculation. ρBCP(r), ∇ 𝜌 𝐫 , electron density and the Laplacian of electron density 
at the BCPs; ε, bond ellipticity; d1, d2, the distance between BCP and each bonded atom. 
 
 
 
 
 
 
 
 
Figure Sup1.Normal probability plot of (F2o-F2c) using program DRKplot (Zhurov, Zhurova& 
Pinkerton, J. Appl. Cryst. (2008) 41, 340–349). Weighting scheme used: W= 1/ [σ(F2)]2. 
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sinmax/ is 1.04 Å-1 
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Figure Sup2. Variation of scale factor, Σ (Fo2)/ Σ (Fc2) with respect to resolution, obtained 
using program DRKplot (Zhurov, Zhurova& Pinkerton, J. Appl. Cryst. (2008) 41, 340–349). 
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Figure Sup3. Fractal dimension (df) vs. residual electron density ρ(Fo-Fc) using all reflections. 
(Meindl, K & Henn, J., Acta Cryst. (2008). A64, 404-418). sinmax/ is 1.04 Å-1.   
 
 
 
 
